Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrins
- 1 October 1988
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 46 (3), 217-222
- https://doi.org/10.1016/0378-5173(88)90081-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Improvement of oral and rectal bioavailabilities of carmofur by methylated β-cyclodextrin complexationsInternational Journal of Pharmaceutics, 1987
- Hydroxypropyl-β Cyclodextrin Derivatives: Influence of Average Degree of Substitution on Complexing Ability and Surface ActivityJournal of Pharmaceutical Sciences, 1986
- Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugsInternational Journal of Pharmaceutics, 1986
- Solubilization of drugs by modified β-cyclodextrinsInternational Journal of Pharmaceutics, 1985
- Amorphous Water-Soluble Derivatives of Cyclodextrins: Nontoxic Dissolution Enhancing ExcipientsJournal of Pharmaceutical Sciences, 1985
- Improvement of dissolution and absorption characteristics of phenytoin by a water-soluble β-cyclodextrin-epichlorohydrin polymerInternational Journal of Pharmaceutics, 1985
- Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.Journal of Pharmacobio-Dynamics, 1982
- Inclusi on complexations of steroid hormones with cyclodextrins in water and in solid phaseInternational Journal of Pharmaceutics, 1982
- A new method to determine the irritation of drugs after intramuscular injection in rabbitsToxicology and Applied Pharmacology, 1967
- Studies on Pharmaceutical Preparations. XIIIYAKUGAKU ZASSHI, 1962